Stock Events

Santen Pharmaceutical. (SNPHF) Q3 2024 Earnings

6AugConfirmed
Nov 22
Q4 2023
Q2 2024
Q3 2024
-72.84
-48.5
-24.16
0.18

Details

Expected EPS
0.161444562528
Actual EPS
0.18381308
Surprise EPS
0.02
Surprise Percent
+13.86%

Description

Santen Pharmaceutical. (SNPHF) has reported earnings of 0.18381308 per share for Q3 2024.

0 Comments

Share your thoughts